KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Inventory: 2009-2025

Historic Inventory for Bausch Health Companies (BHC) over the last 17 years, with Sep 2025 value amounting to $1.6 billion.

  • Bausch Health Companies' Inventory fell 3.44% to $1.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 billion, marking a year-over-year decrease of 3.44%. This contributed to the annual value of $1.6 billion for FY2024, which is 3.30% up from last year.
  • As of Q3 2025, Bausch Health Companies' Inventory stood at $1.6 billion, which was down 3.44% from $1.7 billion recorded in Q2 2025.
  • Bausch Health Companies' Inventory's 5-year high stood at $1.7 billion during Q3 2024, with a 5-year trough of $993.0 million in Q4 2021.
  • In the last 3 years, Bausch Health Companies' Inventory had a median value of $1.6 billion in 2025 and averaged $1.5 billion.
  • As far as peak fluctuations go, Bausch Health Companies' Inventory declined by 13.56% in 2021, and later spiked by 41.65% in 2023.
  • Over the past 5 years, Bausch Health Companies' Inventory (Quarterly) stood at $993.0 million in 2021, then grew by 9.77% to $1.1 billion in 2022, then skyrocketed by 41.65% to $1.5 billion in 2023, then rose by 3.30% to $1.6 billion in 2024, then dropped by 3.44% to $1.6 billion in 2025.
  • Its last three reported values are $1.6 billion in Q3 2025, $1.7 billion for Q2 2025, and $1.6 billion during Q1 2025.